© Foto: Christian Schultz/dpa
© 2024 wallstreetONLINE
Realtime | Geld | Brief | Zeit |
---|---|---|---|
119,02 | 119,20 | 08:34 | |
119,02 | 119,20 | 08:33 |
© Foto: Christian Schultz/dpa
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01:37 | Novo Nordisk's Amycretin Shows Promise in Early Trials | ||
01:34 | Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports | ||
Di | US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month | ||
Di | Novo Nordisk says Ozempic a "very likely" target in next Medicare drug pricing talks | ||
Di | Ozempic 'Very Likely' to Face Drug Price Negotiations, Novo Says |